Cost-Effectiveness of Tepotinib Versus Capmatinib for the Treatment of Adult Patients With Metastatic Non–Small Cell Lung Cancer Harboring Mesenchymal–Epithelial Transition Exon 14 Skipping

Autor:	Mo Yang, Helene Vioix, Rameet Sachdev, Matthew Stargardter, Jon Tosh, Boris M. Pfeiffer, Paul K. Paik
Rok vydání:	2023
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 26:487-497
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.11.018
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c4fb97099898b9580b29bdf3ec707033 https://doi.org/10.1016/j.jval.2022.11.018 Zobrazit plný text záznamu Full Text from ScienceDirect